about
Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cellsPyruvate Dehydrogenase Kinases: Therapeutic Targets for Diabetes and CancersPDH activation during in vitro muscle contractions in PDH kinase 2 knockout mice: effect of PDH kinase 1 compensationPyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) deficiency attenuates the long-term negative effects of a high-saturated fat dietPrevention of salt-induced renal injury by activation of NAD(P)H:quinone oxidoreductase 1, associated with NADPH oxidaseRole of pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) in glucose homoeostasis during starvationFasting induces ketoacidosis and hypothermia in PDHK2/PDHK4-double-knockout miceDifferentially expressed genes in cultured aortic smooth muscle cells by cholesterol-loading.Dimethylfumarate attenuates restenosis after acute vascular injury by cell-specific and Nrf2-dependent mechanismsPhosphorylation status of pyruvate dehydrogenase distinguishes metabolic phenotypes of cultured rat brain astrocytes and neurons.O-GlcNAc Modification: Friend or Foe in Diabetic Cardiovascular Disease.Microarray analysis of papillary thyroid cancers in KoreanPyruvate dehydrogenase kinase-4 contributes to the recirculation of gluconeogenic precursors during postexercise glycogen recovery.Dimethylfumarate suppresses adipogenic differentiation in 3T3-L1 preadipocytes through inhibition of STAT3 activityCarbohydrate-response element-binding protein deletion alters substrate utilization producing an energy-deficient liver.Overview of the molecular and biochemical basis of branched-chain amino acid catabolism.Targeted disruption of ROCK1 causes insulin resistance in vivo.Modified apolipoprotein (apo) A-I by artificial sweetener causes severe premature cellular senescence and atherosclerosis with impairment of functional and structural properties of apoA-I in lipid-free and lipid-bound state.Regulation of pyruvate metabolism in metabolic-related diseases.Physiological effect and therapeutic application of alpha lipoic acid.Association of pyruvate dehydrogenase kinase 4 gene polymorphisms with type 2 diabetes and metabolic syndrome.Inflammation increases pyruvate dehydrogenase kinase 4 (PDK4) expression via the Jun N-Terminal Kinase (JNK) pathway in C2C12 cells.Impaired growth and neurological abnormalities in branched-chain alpha-keto acid dehydrogenase kinase-deficient mice.Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice.Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism.Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/reperfusion injury.Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation.Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy.Metabolic Connection of Inflammatory Pain: Pivotal Role of a Pyruvate Dehydrogenase Kinase-Pyruvate Dehydrogenase-Lactic Acid Axis.Protective role of clusterin/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells.Role of pyruvate dehydrogenase kinase 4 in regulating PDH activation during acute muscle contraction.Glucosamine increases vascular contraction through activation of RhoA/Rho kinase pathway in isolated rat aorta.Hypocholesterolemic effect of naringin associated with hepatic cholesterol regulating enzyme changes in ratsAssay of the pyruvate dehydrogenase complex by coupling with recombinant chicken liver arylamine N-acetyltransferaseEstrogen controls branched-chain amino acid catabolism in female rats
P50
Q24320179-01C27184-E8C3-4170-9356-DF7EE81CCED3Q26822845-174ACBB8-81BE-438C-90FD-9471763ED7E5Q28307470-18E56C6A-BB4D-4EE2-BDA0-B7E341A4D498Q28510446-5B25EF2B-C29B-4491-80E2-9FC8FB3A69EBQ28566927-48D6C64F-A10D-45DA-9021-F2CF3C7EE688Q28588431-1B737538-F4AC-49F9-8BBB-5CA3EFABD397Q28588611-071C9DA0-FFEB-47F3-8095-79453B98EE72Q31931417-226F87AB-BD60-4409-B939-7710EF7BECC8Q33865212-8D5010D7-0670-49F9-9567-4F6F37641B46Q34043021-8EA0EAD0-C04D-4F09-A01B-8AC57204C619Q34101859-56D7C864-B6B5-4F34-950E-D9C4E532C8D1Q34385039-3262CD66-A180-463B-80EB-B6F3D00EFD95Q34389732-3440C066-8C9A-4107-B89F-E5921CBDDFD8Q34700280-3CBDB7CC-EC4D-46D5-82D1-32B8A2D03319Q34718729-2AE06F9C-EB6E-4D27-8348-ECD8EABAD052Q36147726-237D6AC3-EBB0-4007-BD8A-BCE267B80264Q37169423-E36AE820-B0B4-4465-ACCC-B7E22879CECBQ37460991-2D539DBE-5CC6-4E3A-ABFB-51DA1789CE9DQ38161453-B1BBD593-9764-4C8A-80ED-2BBBEE9C1C6CQ38227417-8A7A4337-4475-4735-9DA7-4A2535021405Q38469402-B3F342D6-E637-4F78-9BCF-877CBABC0006Q38805982-46FD1683-0D70-4DA2-98E8-3E1F08637DD5Q39086758-11DC5B46-F318-41C8-84C0-89557A75488EQ41328950-EA11940E-6270-4C45-A137-2BC7D67DB9BEQ42523283-FCEF55FA-61DF-4EC1-8A0C-0B14E6C73AD5Q43264207-DE3ACB14-0FCD-4C54-9B9F-671F7E5591ADQ46116517-4B4CF95D-BEE5-4294-B540-8634E7B4402DQ46847336-56D4B577-95F3-41B7-996D-E3F011E6546DQ48072091-9D16235C-4406-4BB5-8454-9E2EF16CB7C6Q53499214-CC7A312C-299A-41E9-B36C-86D6238840D9Q54540959-B28CA5F0-8B16-4574-92E8-16362E7B3FE2Q54579486-D064B541-3E9C-415D-BC95-B0F33892660CQ73095523-6A6C4602-94C6-4D15-8FA7-52A81610F9FBQ79960614-0257C507-9B22-4476-AA92-CC74B3FE5889Q80822930-CC8E3827-C15A-4787-B3C8-174C81C7EBBE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nam Ho Jeoung
@ast
Nam Ho Jeoung
@en
Nam Ho Jeoung
@es
Nam Ho Jeoung
@nl
Nam Ho Jeoung
@sl
type
label
Nam Ho Jeoung
@ast
Nam Ho Jeoung
@en
Nam Ho Jeoung
@es
Nam Ho Jeoung
@nl
Nam Ho Jeoung
@sl
prefLabel
Nam Ho Jeoung
@ast
Nam Ho Jeoung
@en
Nam Ho Jeoung
@es
Nam Ho Jeoung
@nl
Nam Ho Jeoung
@sl
P106
P31
P496
0000-0002-7584-3761